GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $142,000 | -48.2% | 4,015 | -36.9% | 0.09% | -55.7% |
| Q3 2016 | $274,000 | -4.5% | 6,365 | -3.8% | 0.20% | -8.6% |
| Q2 2016 | $287,000 | 0.0% | 6,615 | -6.7% | 0.22% | -4.3% |
| Q1 2016 | $287,000 | -4.0% | 7,090 | -4.3% | 0.23% | -5.3% |
| Q4 2015 | $299,000 | +41.0% | 7,405 | +34.5% | 0.24% | +40.8% |
| Q3 2015 | $212,000 | -33.5% | 5,505 | -28.1% | 0.17% | -24.3% |
| Q2 2015 | $319,000 | -11.9% | 7,655 | -2.4% | 0.23% | -8.7% |
| Q1 2015 | $362,000 | +2.0% | 7,840 | -5.7% | 0.25% | +9.1% |
| Q4 2014 | $355,000 | -9.7% | 8,310 | -2.9% | 0.23% | -0.9% |
| Q3 2014 | $393,000 | -16.2% | 8,555 | -2.5% | 0.23% | -17.4% |
| Q2 2014 | $469,000 | -6.6% | 8,770 | -6.6% | 0.28% | -15.8% |
| Q1 2014 | $502,000 | -3.8% | 9,390 | -4.0% | 0.34% | -4.3% |
| Q4 2013 | $522,000 | +4.0% | 9,780 | -2.3% | 0.35% | -8.6% |
| Q3 2013 | $502,000 | -0.2% | 10,010 | -0.5% | 0.38% | -1.0% |
| Q2 2013 | $503,000 | – | 10,060 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |